Healthcare Press

Competition Commission probing price of Covid-19 treatment remdesivir

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Health Health Headlines News

Activists and researchers complain about the charge for treatment imported from the US

The Competition Commission is investigating the price of US pharmaceutical manufacturer Gilead Science’s coronavirus treatment remdesivir and prices charged by generic firms to which it granted manufacturing licences after a complaint by activists and researchers.

Commission spokesperson Makunga Siyabulela said on Monday that the organisation received a request from non-profit organisation the Health Justice Initiative and Wits research unit Ezintsha to examine the price of remdesivir. “It is ... currently under investigation and remedies are likely to be behavioural and/or an administrative penalty, if there is a finding of a contravention,” he said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

SANBS looking at blood plasma as possible COVID-19 treatmentAs researchers across the globe, including South Africa, do their bit to find a vaccine for COVID-19, SANBS is also partaking in trials.
Source: eNCA - 🏆 49. / 51 Read more »

SA's COVID-19 death toll exceeds 14,000The health department reported 47 COVID-19 related deaths in the last 24 hours.
Source: eNCA - 🏆 49. / 51 Read more »